Pathstone Holdings’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Sell
68,741
-4,765
-6% -$23.6K ﹤0.01% 2072
2026
Q1
$342K Sell
73,506
-33,236
-31% -$173K ﹤0.01% 1919
2025
Q4
$535K Sell
106,742
-3,356
-3% -$17.5K ﹤0.01% 1728
2025
Q3
$560K Sell
110,098
-22,329
-17% -$98.4K ﹤0.01% 1717
2025
Q2
$572K Sell
132,427
-26,232
-17% -$130K ﹤0.01% 1662
2025
Q1
$958K Sell
158,659
-67,359
-30% -$341K ﹤0.01% 1409
2024
Q4
$894K Sell
226,018
-42,691
-16% -$191K ﹤0.01% 1420
2024
Q3
$1.57M Sell
268,709
-146,113
-35% -$720K 0.01% 1124
2024
Q2
$1.79M Sell
414,822
-23,562
-5% -$113K 0.01% 981
2024
Q1
$2.06M Buy
438,384
+130,823
+43% +$501K 0.01% 880
2023
Q4
$1.51M Buy
+307,561
New +$1.51M 0.01% 850

Other funds holding MPT

Pathstone Holdings's MPT Position: Q2 2026 in Review

Pathstone Holdings reduced its Medical Properties Trust (MPT) stake by 6.5% in Q2 2026, selling an estimated $23.6K and leaving 68,741 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #2072.

Pathstone Holdings first reported a position in MPT in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.06M in Q1 2024. 488 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Pathstone Holdings held 68,741 shares of Medical Properties Trust worth $319K as of Q2 2026.
  • Pathstone Holdings sold 4,765 Medical Properties Trust shares in Q2 2026, an estimated $23.6K.
  • Medical Properties Trust made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2072 holding.
  • Pathstone Holdings first reported a position in Medical Properties Trust in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Medical Properties Trust position peaked at $2.06M in Q1 2024.
  • 488 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.